These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 1352439)
21. Assessment of c-erbB-2 amplification by immunohistochemistry in paraffin-embedded breast cancer. Kerns BJ; Jordan PA; Huper G; Marks JR; Iglehart JD; Layfied LJ Mod Pathol; 1993 Nov; 6(6):673-8. PubMed ID: 7905629 [TBL] [Abstract][Full Text] [Related]
22. Genetic instability in cancer tissues analyzed by random amplified polymorphic DNA PCR. Wang J; Wang Q; Ye F Chin Med J (Engl); 2002 Mar; 115(3):430-2. PubMed ID: 11940382 [TBL] [Abstract][Full Text] [Related]
23. Amplification and rearrangement of c-erb B proto-oncogenes in cancer of human female genital tract. Zhang X; Silva E; Gershenson D; Hung MC Oncogene; 1989 Aug; 4(8):985-9. PubMed ID: 2569708 [TBL] [Abstract][Full Text] [Related]
24. Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer. Schneider PM; Hung MC; Chiocca SM; Manning J; Zhao XY; Fang K; Roth JA Cancer Res; 1989 Sep; 49(18):4968-71. PubMed ID: 2569928 [TBL] [Abstract][Full Text] [Related]
25. Characterization of topoisomerase II alpha gene amplification and deletion in breast cancer. Järvinen TA; Tanner M; Bärlund M; Borg A; Isola J Genes Chromosomes Cancer; 1999 Oct; 26(2):142-50. PubMed ID: 10469452 [TBL] [Abstract][Full Text] [Related]
26. Characterization of a high copy number amplification at 6q24 in pancreatic cancer identifies c-myb as a candidate oncogene. Wallrapp C; Müller-Pillasch F; Solinas-Toldo S; Lichter P; Friess H; Büchler M; Fink T; Adler G; Gress TM Cancer Res; 1997 Aug; 57(15):3135-9. PubMed ID: 9242439 [TBL] [Abstract][Full Text] [Related]
27. Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry. Salido M; Tusquets I; Corominas JM; Suarez M; Espinet B; Corzo C; Bellet M; Fabregat X; Serrano S; Solé F Breast Cancer Res; 2005; 7(2):R267-73. PubMed ID: 15743507 [TBL] [Abstract][Full Text] [Related]
28. DNA amplification of the c-myc and c-erbB-1 genes in a human stomach cancer. Nomura N; Yamamoto T; Toyoshima K; Ohami H; Akimaru K; Sasaki S; Nakagami Y; Kanauchi H; Shoji T; Hiraoka Y Jpn J Cancer Res; 1986 Dec; 77(12):1188-92. PubMed ID: 3102422 [TBL] [Abstract][Full Text] [Related]
29. [Amplification of nucleotide sequences homologous to the viral myc oncogene in DNA of colonic mucosa in a patient with cancer of the same location]. Seĭts IF; Fedorov SN; Serova OM; Kalinovskiĭ VP; Kniazev PG Vopr Onkol; 1985; 31(8):52-6. PubMed ID: 4036067 [TBL] [Abstract][Full Text] [Related]
30. [Preliminary studies on c-erbB-2 protooncogene in breast cancer]. He LW Zhonghua Zhong Liu Za Zhi; 1992 May; 14(3):171-4. PubMed ID: 1356719 [TBL] [Abstract][Full Text] [Related]
31. Aberrant hypermethylation at the bcl-2 locus at 18q21 in human lung cancers. Nagatake M; Osada H; Kondo M; Uchida K; Nishio M; Shimokata K; Takahashi T; Takahashi T Cancer Res; 1996 Apr; 56(8):1886-91. PubMed ID: 8620509 [TBL] [Abstract][Full Text] [Related]
32. Tumorigenicity assay of the human mammary carcinoma cell line MCF-7. Marics I; Adelaide J; Rosnet O; Planche J; Pirisi V; Birnbaum D Anticancer Res; 1989; 9(6):1627-31. PubMed ID: 2560622 [TBL] [Abstract][Full Text] [Related]
33. Determination of HER-2/neu amplification and expression in tumor tissue and cultured cells using a simple, phenol free method for nucleic acid isolation. Kury FD; Schneeberger C; Sliutz G; Kubista E; Salzer H; Medl M; Leodolter S; Swoboda H; Zeillinger R; Spona J Oncogene; 1990 Sep; 5(9):1403-8. PubMed ID: 1699198 [TBL] [Abstract][Full Text] [Related]
34. [Amplification of myc-specific sequences in human colonic cancer]. Serova OM; Shpatar' TV; Fedorov SN; Kniazev PG; Novikov LB Vopr Onkol; 1986; 32(8):89-92. PubMed ID: 3765514 [TBL] [Abstract][Full Text] [Related]
35. Gene amplification in gastric and esophageal adenocarcinomas. Houldsworth J; Cordon-Cardo C; Ladanyi M; Kelsen DP; Chaganti RS Cancer Res; 1990 Oct; 50(19):6417-22. PubMed ID: 2400999 [TBL] [Abstract][Full Text] [Related]
37. c-erbB-2 expression in primary gastric carcinomas and their metastases. David L; Seruca R; Nesland JM; Soares P; Sansonetty F; Holm R; Børresen AL; Sobrinho-Simões M Mod Pathol; 1992 Jul; 5(4):384-90. PubMed ID: 1353880 [TBL] [Abstract][Full Text] [Related]
38. Topoisomerase II alpha co-amplification with erbB2 in human primary breast cancer and breast cancer cell lines: relationship to m-AMSA and mitoxantrone sensitivity. Smith K; Houlbrook S; Greenall M; Carmichael J; Harris AL Oncogene; 1993 Apr; 8(4):933-8. PubMed ID: 8096076 [TBL] [Abstract][Full Text] [Related]
39. Determination of HER2/neu status in uterine serous papillary carcinoma: Comparative analysis of immunohistochemistry and fluorescence in situ hybridization. Santin AD; Bellone S; Van Stedum S; Bushen W; De Las Casas LE; Korourian S; Tian E; Roman JJ; Burnett A; Pecorelli S Gynecol Oncol; 2005 Jul; 98(1):24-30. PubMed ID: 15894362 [TBL] [Abstract][Full Text] [Related]
40. [Correlation between DNA content and amplification of oncogenes (c-myc, L-myc, c-erbB-2) and correlation with prognosis in 143 cases of resected lung cancer]. Chiba W; Sawai S; Hanawa T; Ishida H; Matsui T; Kosaba S; Watanabe S; Hatakenaka R; Matsubara Y; Funatsu T Gan To Kagaku Ryoho; 1993 Apr; 20(6):824-7. PubMed ID: 8098200 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]